Skip to main content
SpringerLink
Log in

Stem Cells Treatment to Combat Cancer and Genetic Disease: From Stem Cell Therapy to Gene-Editing Correction

  • Chapter
  • First Online:
Stem Cells for Cancer and Genetic Disease Treatment

Part of the book series: Stem Cells in Clinical Applications ((SCCA))

Abstract

Stem cells have a great potential to lead to the creation or growths of specific cells within an organism. Certain types of stem cells have used to regenerate blood and immune system, after a course of high-dose chemotherapy, some cancers as well as the use of these cells for other cell recoveries have been proven. The progress of medical science in the treatment of cancer patients and patient with various genetic diseases in recent years has been markedly improved. One of these treatments includes gene editing along with stem cells to treat some blood disorders, cancer, genetic and immune disorders. Recently, gene editing along with stem cell therapy shows a promising opportunity to combat genetic conditions of malignancies caused by a defect in the gene for beta-globin, a component of hemoglobin. In this chapter, we attempt to optimize the design and delivery of new proposed single or combined stem cell therapies combating cancer and genetic disease. Besides, we attempt to discuss utilities of these techniques such as the correction of stem cells matured into red blood cells in the laboratory, which leads to increased levels of normal adult hemoglobin and decreased levels of the sickle form during a procedure using gene-editing tool to repair the defective beta-globin gene in blood stem cells from people with sickle cell disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abrate A, Buono R, Canu T, Esposito A, Del Maschio A et al (2014) Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression. Eur J Cancer 50:2478–2488

    CAS  PubMed  Google Scholar 

  • Ahmed AU, Thaci B, Alexiades NG, Han Y, Qian S et al (2011) Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma. Mol Ther 19:1714–1726

    CAS  PubMed  PubMed Central  Google Scholar 

  • Ahn J, Lee H, Seo K, Kang S, Ra J, Youn H (2013) Anti-tumor effect of adipose tissue derived-mesenchymal stem cells expressing interferon-beta and treatment with cisplatin in a xenograft mouse model for canine melanoma. PLoS One 8:e74897

    CAS  PubMed  PubMed Central  Google Scholar 

  • Alexiades NG, Auffinger B, Kim CK, Hasan T, Lee G et al (2015) MMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells. Stem Cell Res 15:598–607

    CAS  PubMed  PubMed Central  Google Scholar 

  • Amano S, Li S, Gu C, Gao Y, Koizumi S et al (2009) Use of genetically engineered bone marrow-derived mesenchymal stem cells for glioma gene therapy. Int J Oncol 35:1265–1270

    CAS  PubMed  Google Scholar 

  • Amano S, Gu C, Koizumi S, Tokuyama T, Namba H (2011) Timing of ganciclovir administration in glioma gene therapy using HSVtk gene-transduced mesenchymal stem cells. Cancer Genomics Proteomics 8:245–250

    CAS  PubMed  Google Scholar 

  • Amato MP, Derfuss T, Hemmer B, Liblau R, Montalban X et al (2017) Environmental modifiable risk factors for multiple sclerosis: report from the 2016 ECTRIMS focused workshop Mult Scler 1352458516686847

    Google Scholar 

  • Ardeshiry Lajimi A, Hagh MF, Saki N, Mortaz E, Soleimani M, Rahim F (2013) Feasibility of cell therapy in multiple sclerosis: a systematic review of 83 studies. Int J Hematol Oncol Stem Cell Res 7:15–33

    PubMed  PubMed Central  Google Scholar 

  • Avior Y, Sagi I, Benvenisty N (2016) Pluripotent stem cells in disease modelling and drug discovery. Nat Rev Mol Cell Biol 17:170–182

    CAS  PubMed  Google Scholar 

  • Bahrambeigi V, Ahmadi N, Salehi R, Javanmard SH (2015) Genetically modified murine adipose-derived mesenchymal stem cells producing interleukin-2 favor B16F10 melanoma cell proliferation. Immunol Investig 44:216–236

    CAS  Google Scholar 

  • Bailer SM, Funk C, Riedl A, Ruzsics Z (2017) Herpesviral vectors and their application in oncolytic therapy, vaccination, and gene transfer. Virus Genes 53(5):741–748

    CAS  PubMed  Google Scholar 

  • Ballios BG, van der Kooy D (2010) Biology and therapeutic potential of adult retinal stem cells. Can J Ophthalmol 45:342–351

    PubMed  Google Scholar 

  • Barkho BZ, Zhao X (2011) Adult neural stem cells: response to stroke injury and potential for therapeutic applications. Curr Stem Cell Res Ther 6:327–338

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bauer TR Jr, Allen JM, Hai M, Tuschong LM, Khan IF et al (2008) Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors. Nat Med 14:93–97

    CAS  PubMed  Google Scholar 

  • Bera A, Sen D (2017) Promise of adeno-associated virus as a gene therapy vector for cardiovascular diseases. Heart Fail Rev 22:795–823

    CAS  PubMed  Google Scholar 

  • Bexell D, Gunnarsson S, Tormin A, Darabi A, Gisselsson D et al (2009) Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 17:183–190

    CAS  PubMed  Google Scholar 

  • Bexell D, Gunnarsson S, Svensson A, Tormin A, Henriques-Oliveira C et al (2012) Rat multipotent mesenchymal stromal cells lack long-distance tropism to 3 different rat glioma models. Neurosurgery 70:731–739

    PubMed  Google Scholar 

  • Bigger BW, Siapati EK, Mistry A, Waddington SN, Nivsarkar MS et al (2006) Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX. Gene Ther 13:117–126

    CAS  PubMed  Google Scholar 

  • Blackadar CB (2016) Historical review of the causes of cancer. World J Clin Oncol 7:54–86

    PubMed  PubMed Central  Google Scholar 

  • Broxmeyer HE (2011) Insights into the biology of cord blood stem/progenitor cells. Cell Prolif 44(Suppl 1):55–59

    PubMed  Google Scholar 

  • Chang DY, Yoo SW, Hong Y, Kim S, Kim SJ et al (2010) The growth of brain tumors can be suppressed by multiple transplantation of mesenchymal stem cells expressing cytosine deaminase. Int J Cancer 127:1975–1983

    CAS  PubMed  Google Scholar 

  • Choi SA, Lee JY, Wang KC, Phi JH, Song SH et al (2012) Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas. Eur J Cancer 48:129–137

    CAS  PubMed  Google Scholar 

  • Choi SA, Lee YE, Kwak PA, Lee JY, Kim SS et al (2015) Clinically applicable human adipose tissue-derived mesenchymal stem cells delivering therapeutic genes to brainstem gliomas. Cancer Gene Ther 22:302–311

    CAS  PubMed  Google Scholar 

  • Christopher PR, Kingsley PA, Singh Bedi H, Singh Kwatra K, Rathore S, Das KC (2015) Large mid-esophageal granular cell tumor: benign versus malignant. Rare Tumors 7:5772

    PubMed  PubMed Central  Google Scholar 

  • Connelly JP, Kwon EM, Gao Y, Trivedi NS, Elkahloun AG et al (2014) Targeted correction of RUNX1 mutation in FPD patient-specific induced pluripotent stem cells rescues megakaryopoietic defects. Blood 124:1926–1930

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cuenca N, Fernandez-Sanchez L, Campello L, Maneu V, De la Villa P et al (2014) Cellular responses following retinal injuries and therapeutic approaches for neurodegenerative diseases. Prog Retin Eye Res 43:17–75

    CAS  PubMed  Google Scholar 

  • Dembinski JL, Wilson SM, Spaeth EL, Studeny M, Zompetta C et al (2013) Tumor stroma engraftment of gene-modified mesenchymal stem cells as anti-tumor therapy against ovarian cancer. Cytotherapy 15:20–32

    CAS  PubMed  PubMed Central  Google Scholar 

  • Deng YJ, Zhang SL, Shang XY, Fu PF, Cui XY (2005) [Transfection and expression of hRI gene on human umbilical blood stem cells and gene therapy for mouse melanoma]. Sheng wu gong cheng xue bao 21:36–41

    Google Scholar 

  • Deng Q, Zhang Z, Feng X, Li T, Liu N et al (2014) TRAIL-secreting mesenchymal stem cells promote apoptosis in heat-shock-treated liver cancer cells and inhibit tumor growth in nude mice. Gene Ther 21:317–327

    CAS  PubMed  Google Scholar 

  • Deyle DR, Khan IF, Ren G, Wang PR, Kho J et al (2012) Normal collagen and bone production by gene-targeted human osteogenesis imperfecta iPSCs. Mol Ther 20:204–213

    CAS  PubMed  Google Scholar 

  • Dutta UR, Rajitha P, Pidugu VK, Dalal AB (2011) Cytogenetic abnormalities in 1162 couples with recurrent miscarriages in southern region of India: report and review. J Assist Reprod Genet 28:145–149

    PubMed  Google Scholar 

  • Dwyer RM, Ryan J, Havelin RJ, Morris JC, Miller BW et al (2011) Mesenchymal stem cell-mediated delivery of the sodium iodide symporter supports radionuclide imaging and treatment of breast cancer. Stem Cells 29:1149–1157

    CAS  PubMed  PubMed Central  Google Scholar 

  • Earls JK, Jin S, Ye K (2013) Mechanobiology of human pluripotent stem cells. Tissue Eng B Rev 19:420–430

    CAS  Google Scholar 

  • Ebrahimi A, Rahim F (2014) Recent immunomodulatory strategies in transplantation. Immunol Investig 43:829–837

    CAS  Google Scholar 

  • Ebrahimi A, Hosseini SA, Rahim F (2014) Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges. Cent Eur J Immunol 39:400–409

    CAS  PubMed  PubMed Central  Google Scholar 

  • Elmore S (2007) Apoptosis: a review of programmed cell death. Toxicol Pathol 35:495–516

    CAS  PubMed  PubMed Central  Google Scholar 

  • Emery DW (2004) Gene therapy for genetic diseases: on the horizon. Clin Appl Immunol Rev 4:411–422

    CAS  Google Scholar 

  • Farajkhoda T (2017) An overview on ethical considerations in stem cell research in Iran and ethical recommendations: a review. Int J Reprod Biomed 15:67–74

    Google Scholar 

  • Fareed M, Afzal M (2017) Genetics of consanguinity and inbreeding in health and disease. Ann Hum Biol 44:99–107

    PubMed  Google Scholar 

  • Fei S, Qi X, Kedong S, Guangchun J, Jian L, Wei Q (2012) The antitumor effect of mesenchymal stem cells transduced with a lentiviral vector expressing cytosine deaminase in a rat glioma model. J Cancer Res Clin Oncol 138:347–357

    PubMed  Google Scholar 

  • Feng R, Hu J, Wu J, Lang L, Ma C et al (2017) Comprehensive preoperative work-up and surgical treatment of low grade tumor/benign lesion related temporal lobe epilepsy. J Clin Neurosci 39:203–208

    PubMed  Google Scholar 

  • Firth AL, Menon T, Parker GS, Qualls SJ, Lewis BM et al (2015) Functional gene correction for cystic fibrosis in lung epithelial cells generated from patient iPSCs. Cell Rep 12:1385–1390

    CAS  PubMed  PubMed Central  Google Scholar 

  • Flynn R, Grundmann A, Renz P, Hanseler W, James WS et al (2015) CRISPR-mediated genotypic and phenotypic correction of a chronic granulomatous disease mutation in human iPS cells. Exp Hematol 43:838–48.e3

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fougeroux C, Holst PJ (2017) Future prospects for the development of cost-effective adenovirus vaccines. Int J Mol Sci 18(4):686

    PubMed Central  Google Scholar 

  • Galeev R, Karlsson C, Baudet A, Larsson J (2017) Forward RNAi screens in human hematopoietic stem cells. Methods Mol Biol 1622:29–50

    CAS  PubMed  Google Scholar 

  • Gamez A, Yuste-Checa P, Brasil S, Briso-Montiano A, Desviat LR et al (2018) Protein misfolding diseases: prospects of pharmacological treatment. Clin Genet 93(3):450–458

    CAS  PubMed  Google Scholar 

  • Gammaitoni L, Lucchi S, Bruno S, Tesio M, Gunetti M et al (2006) Serial transplantations in nonobese diabetic/severe combined immunodeficiency mice of transduced human CD34+ cord blood cells: efficient oncoretroviral gene transfer and ex vivo expansion under serum-free conditions. Stem Cells 24:1201–1212

    CAS  PubMed  Google Scholar 

  • Gao P, Ding Q, Wu Z, Jiang H, Fang Z (2010a) Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. Cancer Lett 290:157–166

    CAS  PubMed  Google Scholar 

  • Gao Y, Yao A, Zhang W, Lu S, Yu Y et al (2010b) Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice. Oncogene 29:2784–2794

    CAS  PubMed  Google Scholar 

  • Gao Y, Guo X, Santostefano K, Wang Y, Reid T et al (2016) Genome therapy of myotonic dystrophy type 1 iPS cells for development of autologous stem cell therapy. Mol Ther 24:1378–1387

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hakkarainen T, Sarkioja M, Lehenkari P, Miettinen S, Ylikomi T et al (2007) Human mesenchymal stem cells lack tumor tropism but enhance the antitumor activity of oncolytic adenoviruses in orthotopic lung and breast tumors. Hum Gene Ther 18:627–641

    CAS  PubMed  Google Scholar 

  • Haley K (2017) Congenital hemolytic anemia. Med Clin North Am 101:361–374

    PubMed  Google Scholar 

  • Hoyos V, Del Bufalo F, Yagyu S, Ando M, Dotti G et al (2015) Mesenchymal stromal cells for linked delivery of oncolytic and apoptotic adenoviruses to non-small-cell lung cancers. Mol Ther 23:1497–1506

    CAS  PubMed  PubMed Central  Google Scholar 

  • Hu W, Wang J, He X, Zhang H, Yu F et al (2011) Human umbilical blood mononuclear cell-derived mesenchymal stem cells serve as interleukin-21 gene delivery vehicles for epithelial ovarian cancer therapy in nude mice. Biotechnol Appl Biochem 58:397–404

    CAS  PubMed  Google Scholar 

  • Iizuka H, Kagoya Y, Kataoka K, Yoshimi A, Miyauchi M et al (2015) Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesis. Exp Hematol 43:849–857

    CAS  PubMed  Google Scholar 

  • Ikezawa M, Cao B, Qu Z, Peng H, Xiao X et al (2003) Dystrophin delivery in dystrophin-deficient DMDmdx skeletal muscle by isogenic muscle-derived stem cell transplantation. Hum Gene Ther 14:1535–1546

    CAS  PubMed  Google Scholar 

  • Jayant RD, Sosa D, Kaushik A, Atluri V, Vashist A et al (2016) Current status of non-viral gene therapy for CNS disorders. Expert Opin Drug Deliv 13:1433–1445

    CAS  PubMed  PubMed Central  Google Scholar 

  • Jeong KY, Lee EJ, Kim SJ, Yang SH, Sung YC, Seong J (2015) Irradiation-induced localization of IL-12-expressing mesenchymal stem cells to enhance the curative effect in murine metastatic hepatoma. Int J Cancer 137:721–730

    CAS  PubMed  Google Scholar 

  • Jiang J, Chen W, Zhuang R, Song T, Li P (2010) The effect of endostatin mediated by human mesenchymal stem cells on ovarian cancer cells in vitro. J Cancer Res Clin Oncol 136:873–881

    CAS  PubMed  Google Scholar 

  • Jin G, Zhou Y, Chai Q, Zhu G, Xu F, Liu F (2013) VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy. J Cancer Res Clin Oncol 139:475–483

    CAS  PubMed  Google Scholar 

  • Joo KM, Park IH, Shin JY, Jin J, Kang BG et al (2009) Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases. Mol Ther 17:570–575

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kanehira M, Xin H, Hoshino K, Maemondo M, Mizuguchi H et al (2007) Targeted delivery of NK4 to multiple lung tumors by bone marrow-derived mesenchymal stem cells. Cancer Gene Ther 14:894–903

    CAS  PubMed  Google Scholar 

  • Kaneti L, Bronshtein T, Malkah Dayan N, Kovregina I, Letko Khait N et al (2016) Nanoghosts as a novel natural nonviral gene delivery platform safely targeting multiple cancers. Nano Lett 16:1574–1582

    CAS  PubMed  Google Scholar 

  • Kaufmann KB, Büning H, Galy A, Schambach A, Grez M (2013) Gene therapy on the move. EMBO Mol Med 5:1642–1661

    CAS  PubMed  PubMed Central  Google Scholar 

  • Khanna S, Gharpure AS (2017) Petroleum carcinogenicity and aerodigestive tract: in context of developing nations. Cureus 9:e1202

    PubMed  PubMed Central  Google Scholar 

  • Kim SK, Kim SU, Park IH, Bang JH, Aboody KS et al (2006) Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin Cancer Res 12:5550–5556

    CAS  PubMed  Google Scholar 

  • Kim KY, Kim SU, Leung PC, Jeung EB, Choi KC (2010) Influence of the prodrugs 5-fluorocytosine and CPT-11 on ovarian cancer cells using genetically engineered stem cells: tumor-tropic potential and inhibition of ovarian cancer cell growth. Cancer Sci 101:955–962

    CAS  PubMed  Google Scholar 

  • Kim JH, Kim JY, Kim SU, Cho KG (2012a) Therapeutic effect of genetically modified human neural stem cells encoding cytosine deaminase on experimental glioma. Biochem Biophys Res Commun 417:534–540

    CAS  PubMed  Google Scholar 

  • Kim KY, Yi BR, Lee HR, Kang NH, Jeung EB et al (2012b) Stem cells with fused gene expression of cytosine deaminase and interferon-beta migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use. Int J Oncol 40:1097–1104

    CAS  PubMed  Google Scholar 

  • Kim SM, Woo JS, Jeong CH, Ryu CH, Lim JY, Jeun SS (2012c) Effective combination therapy for malignant glioma with TRAIL-secreting mesenchymal stem cells and lipoxygenase inhibitor MK886. Cancer Res 72:4807–4817

    CAS  PubMed  Google Scholar 

  • Kim HS, Yi BR, Hwang KA, Kim SU, Choi KC (2013a) Anticancer effects of the engineered stem cells transduced with therapeutic genes via a selective tumor tropism caused by vascular endothelial growth factor toward HeLa cervical cancer cells. Mol Cells 36:347–354

    CAS  PubMed  PubMed Central  Google Scholar 

  • Kim SW, Kim SJ, Park SH, Yang HG, Kang MC et al (2013b) Complete regression of metastatic renal cell carcinoma by multiple injections of engineered mesenchymal stem cells expressing dodecameric TRAIL and HSV-TK. Clin Cancer Res 19:415–427

    CAS  PubMed  Google Scholar 

  • Kim JH, Lee HJ, Song YS (2014a) Stem cell based gene therapy in prostate cancer. Biomed Res Int 2014:549136

    PubMed  PubMed Central  Google Scholar 

  • Kim SM, Woo JS, Jeong CH, Ryu CH, Jang JD, Jeun SS (2014b) Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma. Stem Cells Transl Med 3:172–182

    CAS  PubMed  PubMed Central  Google Scholar 

  • Knoop K, Schwenk N, Schmohl K, Muller A, Zach C et al (2015) Mesenchymal stem cell-mediated, tumor stroma-targeted radioiodine therapy of metastatic colon cancer using the sodium iodide symporter as theranostic gene. J Nucl Med 56:600–606

    CAS  PubMed  Google Scholar 

  • Kosaka H, Ichikawa T, Kurozumi K, Kambara H, Inoue S et al (2012) Therapeutic effect of suicide gene-transferred mesenchymal stem cells in a rat model of glioma. Cancer Gene Ther 19:572–578

    CAS  PubMed  Google Scholar 

  • Krasikova LS, Karshieva SS, Cheglakov IB, Belyavsky AV (2015) [Mesenchymal stem cells expressing cytosine deaminase inhibit growth of murine melanoma B16F10 in vivo]. Mol Biol 49:1007–1015

    CAS  Google Scholar 

  • Kucerova L, Skolekova S, Demkova L, Bohovic R, Matuskova M (2014) Long-term efficiency of mesenchymal stromal cell-mediated CD-MSC/5FC therapy in human melanoma xenograft model. Gene Ther 21:874–887

    CAS  PubMed  Google Scholar 

  • Kugler J, Huhse B, Tralau T, Luch A (2017) Embryonic stem cells and the next generation of developmental toxicity testing. Expert Opin Drug Metab Toxicol 13:833–841

    CAS  PubMed  Google Scholar 

  • Lakota J, Gocarova K, Spanik S (2015) Treatment of metastatic head and neck cancer with mesenchymal stem cells combined with prodrug gene therapy. Exp Oncol 37:298

    CAS  PubMed  Google Scholar 

  • Lau AA, Hemsley KM (2017) Adeno-associated viral gene therapy for mucopolysaccharidoses exhibiting neurodegeneration. J Mol Med 95(10):1043–1052

    CAS  PubMed  Google Scholar 

  • Lee KY (2017) A unified pathogenesis for kidney diseases, including genetic diseases and cancers, by the protein-homeostasis-system hypothesis. Kidney Res Clin Pract 36:132–144

    PubMed  PubMed Central  Google Scholar 

  • Lee HJ, Yang HM, Choi YS, Park SH, Moon SH et al (2013) A therapeutic strategy for metastatic malignant fibrous histiocytoma through mesenchymal stromal cell-mediated TRAIL production. Ann Surg 257:952–960

    PubMed  Google Scholar 

  • Leten C, Trekker J, Struys T, Dresselaers T, Gijsbers R et al (2015) Assessment of bystander killing-mediated therapy of malignant brain tumors using a multimodal imaging approach. Stem Cell Res Ther 6:163

    PubMed  PubMed Central  Google Scholar 

  • Li X, Lu Y, Huang W, Xu H, Chen X et al (2006) In vitro effect of adenovirus-mediated human Gamma Interferon gene transfer into human mesenchymal stem cells for chronic myelogenous leukemia. Hematol Oncol 24:151–158

    CAS  PubMed  Google Scholar 

  • Li L, Li S, Cai T, Wang H, Xie X et al (2016) The targeted inhibitory effects of human amniotic fluid stem cells carrying CXCR4 promoter and DAL-1 on non-small cell lung carcinoma growth. Gene Ther 23:214–222

    CAS  PubMed  Google Scholar 

  • Liu YN, Yan X, Sun Z, Han Q, Zhao RC (2007) [Mice adipose derived Flk-1+ mesenchymal stem cells can ameliorate Duchenne’s muscular dystrophy in Mdx mice for their multilineage potential]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15:306–312

    Google Scholar 

  • Long Q, Yang R, Lu W, Zhu W, Zhou J et al (2017) Adenovirus-mediated truncated Bid overexpression induced by the Cre/LoxP system promotes the cell apoptosis of CD133+ ovarian cancer stem cells. Oncol Rep 37:155–162

    PubMed  Google Scholar 

  • Lopez-Ornelas A, Vergara P, Segovia J (2014) Neural stem cells producing an inducible and soluble form of Gas1 target and inhibit intracranial glioma growth. Cytotherapy 16:1011–1023

    CAS  PubMed  Google Scholar 

  • Ma GL, Zhu XH, Xuan SY, Mao WZ (2012) [Study of inhibiting and killing effects of transgenic LIGHT human umbilical cord blood mesenchymal stem cells on stomach cancer]. Zhonghua wei chang wai ke za zhi 15:1178–1181

    Google Scholar 

  • Mac Gabhann F, Annex BH, Popel AS (2010) Gene therapy from the perspective of systems biology. Curr Opin Mol Ther 12:570–577

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mao W, Zhu X, Tang D, Zhao Y, Zhao B et al (2012) TNF-alpha expression in the UCB-MSCs as stable source inhibits gastric cancers growth in nude mice. Cancer Investig 30:463–472

    CAS  Google Scholar 

  • Marsico C, Kimberlin DW (2017) Congenital cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment. Ital J Pediatr 43:38

    PubMed  PubMed Central  Google Scholar 

  • Masiuk KE, Brown D, Laborada J, Hollis RP, Urbinati F, Kohn DB (2017) Improving gene therapy efficiency through the enrichment of human hematopoietic stem cells. Mol Ther 25(9):2163–2175

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mason EF, Rathmell JC (2011) Cell metabolism: an essential link between cell growth and apoptosis. Biochim Biophys Acta 1813:645–654

    CAS  PubMed  Google Scholar 

  • Matuskova M, Kozovska Z, Toro L, Durinikova E, Tyciakova S et al (2015) Combined enzyme/prodrug treatment by genetically engineered AT-MSC exerts synergy and inhibits growth of MDA-MB-231 induced lung metastases. J Exp Clin Cancer Res 34:33

    PubMed  PubMed Central  Google Scholar 

  • Mavroudi M, Zarogoulidis P, Porpodis K, Kioumis I, Lampaki S et al (2014) Stem cells’ guided gene therapy of cancer: new frontier in personalized and targeted therapy. J Cancer Res Ther 2:22–33

    CAS  Google Scholar 

  • Menon T, Firth AL, Scripture-Adams DD, Galic Z, Qualls SJ et al (2015) Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs. Cell Stem Cell 16:367–372

    CAS  PubMed  PubMed Central  Google Scholar 

  • Mohammadian F, Eatemadi A, Daraee H (2017) Inner ear drug delivery using liposomes. Cell Mol Biol 63:28–33

    CAS  PubMed  Google Scholar 

  • Momtaz R, Ghanem NM, El-Makky NM, Ismail MA (2017) Integrated analysis of SNP, CNV and gene expression data in genetic association studies. Clin Genet 93(3):557–566

    PubMed  Google Scholar 

  • Moniri MR, Sun XY, Rayat J, Dai D, Ao Z et al (2012) TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells. Cancer Gene Ther 19:652–658

    CAS  PubMed  Google Scholar 

  • Morgan JE, Partridge TA (1992) Cell transplantation and gene therapy in muscular dystrophy. Bioessays 14:641–645

    CAS  PubMed  Google Scholar 

  • Murai J (2017) Targeting DNA repair and replication stress in the treatment of ovarian cancer. Int J Clin Oncol 22(4):619–628

    CAS  PubMed  Google Scholar 

  • Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M et al (2004) Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 11:1155–1164

    CAS  PubMed  Google Scholar 

  • Naso MF, Tomkowicz B, Perry WL III, Strohl WR (2017) Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs 31(4):317–334

    CAS  PubMed  PubMed Central  Google Scholar 

  • Navarro S, Moleiro V, Molina-Estevez FJ, Lozano ML, Chinchon R et al (2014) Generation of iPSCs from genetically corrected Brca2 hypomorphic cells: implications in cell reprogramming and stem cell therapy. Stem Cells 32:436–446

    CAS  PubMed  Google Scholar 

  • Naylor S, Chen JY (2010) Unraveling human complexity and disease with systems biology and personalized medicine. Pers Med 7:275–289

    Google Scholar 

  • Niess H, Bao Q, Conrad C, Zischek C, Notohamiprodjo M et al (2011) Selective targeting of genetically engineered mesenchymal stem cells to tumor stroma microenvironments using tissue-specific suicide gene expression suppresses growth of hepatocellular carcinoma. Ann Surg 254:767–774; discussion 74–5

    PubMed  Google Scholar 

  • Niu X, He W, Song B, Ou Z, Fan D et al (2016) Combining single strand oligodeoxynucleotides and CRISPR/Cas9 to correct gene mutations in beta-thalassemia-induced pluripotent stem cells. J Biol Chem 291:16576–16585

    CAS  PubMed  PubMed Central  Google Scholar 

  • O’Neill AC, Jagannathan JP, Ramaiya NH (2017) Evolving cancer classification in the era of personalized medicine: a primer for radiologists. Korean J Radiol 18:6–17

    PubMed  PubMed Central  Google Scholar 

  • Ochakovski GA, Bartz-Schmidt KU, Fischer MD (2017) Retinal gene therapy: surgical vector delivery in the translation to clinical trials. Front Neurosci 11:174

    PubMed  PubMed Central  Google Scholar 

  • Oldfors A, Nordborg C, Rockert L, Parkkila T, Kalimo H (1988) [Primary benign lymphoma—tumor biology, pathology and clinical aspects]. Lakartidningen 85:1797, 99–800

    Google Scholar 

  • Otsu M (2015) Perspectives on stem cell gene therapy for genetic disorders. ISBT Sci Ser 10:231–234

    CAS  Google Scholar 

  • Otsuka A, Nomura T, Rerknimitr P, Seidel JA, Honda T, Kabashima K (2017) The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis. Immunol Rev 278:246–262

    CAS  PubMed  Google Scholar 

  • Pawliuk R, Bachelot T, Wise RJ, Mathews-Roth MM, Leboulch P (1999) Long-term cure of the photosensitivity of murine erythropoietic protoporphyria by preselective gene therapy. Nat Med 5:768–773

    CAS  PubMed  Google Scholar 

  • Porada CD, Almeida-Porada G (2010) Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Adv Drug Deliv Rev 62:1156–1166

    CAS  PubMed  PubMed Central  Google Scholar 

  • Purwanti YI, Chen C, Lam DH, Wu C, Zeng J et al (2014) Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model. Stem Cells Transl Med 3:923–935

    CAS  PubMed  PubMed Central  Google Scholar 

  • Qazi Y, Hamrah P (2013) Gene therapy in corneal transplantation. Semin Ophthalmol 28:287–300

    PubMed  PubMed Central  Google Scholar 

  • Rachakatla RS, Marini F, Weiss ML, Tamura M, Troyer D (2007) Development of human umbilical cord matrix stem cell-based gene therapy for experimental lung tumors. Cancer Gene Ther 14:828–835

    CAS  PubMed  Google Scholar 

  • Rahim F, Allahmoradi H, Salari F, Shahjahani M, Fard AD et al (2013) Evaluation of signaling pathways involved in gamma-globin gene induction using fetal hemoglobin inducer drugs. Int J Hematol Oncol Stem Cell Res 7:41–46

    PubMed  PubMed Central  Google Scholar 

  • Ramnaraine ML, Mathews WE, Clohisy DR (2012) Lentivirus transduction of human osteoclast precursor cells and differentiation into functional osteoclasts. Bone 50:97–103

    PubMed  Google Scholar 

  • Rappaport SM (2016) Genetic factors are not the major causes of chronic diseases. PLoS One 11:e0154387

    PubMed  PubMed Central  Google Scholar 

  • Ren C, Kumar S, Chanda D, Kallman L, Chen J et al (2008) Cancer gene therapy using mesenchymal stem cells expressing interferon-beta in a mouse prostate cancer lung metastasis model. Gene Ther 15:1446–1453

    CAS  PubMed  PubMed Central  Google Scholar 

  • Riley MK, Vermerris W (2017) Recent advances in nanomaterials for gene delivery—a review. Nanomaterials 7

    Google Scholar 

  • Roquette R, Painho M, Nunes B (2017) Spatial epidemiology of cancer: a review of data sources, methods and risk factors. Geospat Health 12:504

    PubMed  Google Scholar 

  • Rouanet M, Lebrin M, Gross F, Bournet B, Cordelier P, Buscail L (2017) Gene therapy for pancreatic cancer: specificity, issues and hopes. Int J Mol Sci 18:1231

    PubMed Central  Google Scholar 

  • Rubanyi GM (2001) The future of human gene therapy. Mol Asp Med 22:113–142

    CAS  Google Scholar 

  • Ryu CH, Park KY, Kim SM, Jeong CH, Woo JS et al (2012) Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma. Biochem Biophys Res Commun 421:585–590

    CAS  PubMed  Google Scholar 

  • Saffari M, Moghimi HR, Dass CR (2016) Barriers to liposomal gene delivery: from application site to the target. Iran J Pharm Res 15:3–17

    PubMed  PubMed Central  Google Scholar 

  • Saki N, Jalalifar MA, Soleimani M, Hajizamani S, Rahim F (2013) Adverse effect of high glucose concentration on stem cell therapy. Int J Hematol Oncol Stem Cell Res 7:34–40

    PubMed  PubMed Central  Google Scholar 

  • Sampaolesi M, Blot S, D’Antona G, Granger N, Tonlorenzi R et al (2006) Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature 444:574–579

    CAS  PubMed  Google Scholar 

  • Schakman O, Thissen JP (2006) Gene therapy with anabolic growth factors to prevent muscle atrophy. Curr Opin Clin Nutr Metab Care 9:207–213

    CAS  PubMed  Google Scholar 

  • Seo KW, Lee HW, Oh YI, Ahn JO, Koh YR et al (2011) Anti-tumor effects of canine adipose tissue-derived mesenchymal stromal cell-based interferon-beta gene therapy and cisplatin in a mouse melanoma model. Cytotherapy 13:944–955

    CAS  PubMed  Google Scholar 

  • Seol HJ, Jin J, Seong DH, Joo KM, Kang W et al (2011) Genetically engineered human neural stem cells with rabbit carboxyl esterase can target brain metastasis from breast cancer. Cancer Lett 311:152–159

    CAS  PubMed  Google Scholar 

  • Shahrabi S, Azizidoost S, Shahjahani M, Rahim F, Ahmadzadeh A, Saki N (2014) New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia. Tumour Biol 35:10627–10633

    CAS  PubMed  Google Scholar 

  • Shawky RM, Elsayed NS, Ibrahim DS, Seifeldin NS (2012) Profile of genetic disorders prevalent in northeast region of Cairo, Egypt. Egypt J Med Hum Genet 13:45–62

    Google Scholar 

  • Sheppard M, Spencer RN, Ashcroft R, David AL (2016) Ethics and social acceptability of a proposed clinical trial using maternal gene therapy to treat severe early-onset fetal growth restriction. Ultrasound Obstet Gynecol 47:484–491

    CAS  PubMed  Google Scholar 

  • Siapati EK, Bigger BW, Kashofer K, Themis M, Thrasher AJ, Bonnet D (2007) Murine leukemia following irradiation conditioning for transplantation of lentivirally-modified hematopoietic stem cells. Eur J Haematol 78:303–313

    CAS  PubMed  Google Scholar 

  • Sideri A, Neokleous N, Brunet De La Grange P, Guerton B, Le Bousse Kerdilles MC et al (2011) An overview of the progress on double umbilical cord blood transplantation. Haematologica 96:1213–1220

    PubMed  PubMed Central  Google Scholar 

  • Skokowa J, Dale DC, Touw IP, Zeidler C, Welte K (2017) Severe congenital neutropenias. Nat Rev Dis Primers 3:17032

    PubMed  PubMed Central  Google Scholar 

  • Song P, He J, Li F, Jin C (2017) Innovative measures to combat rare diseases in China: the national rare diseases registry system, larger-scale clinical cohort studies, and studies in combination with precision medicine research. Intractable Rare Dis Res 6:1–5

    PubMed  PubMed Central  Google Scholar 

  • Stoff-Khalili MA, Rivera AA, Mathis JM, Banerjee NS, Moon AS et al (2007) Mesenchymal stem cells as a vehicle for targeted delivery of CRAds to lung metastases of breast carcinoma. Breast Cancer Res Treat 105:157–167

    PubMed  Google Scholar 

  • Sudhakar A (2009) History of cancer, ancient and modern treatment methods. J Cancer Sci Ther 1:1–4

    PubMed  Google Scholar 

  • Sun N, Zhao H (2014) Seamless correction of the sickle cell disease mutation of the HBB gene in human induced pluripotent stem cells using TALENs. Biotechnol Bioeng 111:1048–1053

    CAS  PubMed  Google Scholar 

  • Tedesco FS, Gerli MF, Perani L, Benedetti S, Ungaro F et al (2012) Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. Sci Transl Med 4:140ra89

    PubMed  Google Scholar 

  • Teng J, Hejazi S, Badr CE, Tannous BA (2014) Systemic anticancer neural stem cells in combination with a cardiac glycoside for glioblastoma therapy. Stem Cells 32:2021–2032

    CAS  PubMed  PubMed Central  Google Scholar 

  • Traebert J, Schneider IJ, Colussi CF, de Lacerda JT (2013) Burden of disease due to cancer in a Southern Brazilian state. Cancer Epidemiol 37:788–792

    PubMed  Google Scholar 

  • Tweedell KS (2017) The adaptability of somatic stem cells: a review. J Stem Cells Regen Med 13:3–13

    PubMed  PubMed Central  Google Scholar 

  • Tyciakova S, Matuskova M, Bohovic R, Polakova K, Toro L et al (2015) Genetically engineered mesenchymal stromal cells producing TNFalpha have tumour suppressing effect on human melanoma xenograft. J Gene Med 17:54–67

    CAS  PubMed  Google Scholar 

  • Uzzaman M, Benveniste RJ, Keller G, Germano IM (2005) Embryonic stem cell-derived astrocytes: a novel gene therapy vector for brain tumors. Neurosurg Focus 19:E6

    PubMed  Google Scholar 

  • Wang Y, Zheng CG, Jiang Y, Zhang J, Chen J et al (2012) Genetic correction of beta-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice. Cell Res 22:637–648

    CAS  PubMed  PubMed Central  Google Scholar 

  • Wang G, Yuan N, Huang S, Feng L, Han R et al (2017) The CNGRCLLII(KLAKLAK)2 peptide shows cytotoxicity against HUVECs by inducing apoptosis: an in vitro and in vivo study. Tumour Biol 39:1010428317701649

    PubMed  Google Scholar 

  • Warnock JN, Daigre C, Al-Rubeai M (2011) Introduction to viral vectors. Methods Mol Biol 737:1–25

    CAS  PubMed  Google Scholar 

  • Warrick E, Garcia M, Chagnoleau C, Chevallier O, Bergoglio V et al (2012) Preclinical corrective gene transfer in xeroderma pigmentosum human skin stem cells. Mol Ther 20:798–807

    CAS  PubMed  Google Scholar 

  • Williams DA (2014) Curing genetic disease with gene therapy. Trans Am Clin Climatol Assoc 125:122–129

    PubMed  PubMed Central  Google Scholar 

  • Williams DA, Croop J, Kelly P (2005) Gene therapy in the treatment of Fanconi anemia, a progressive bone marrow failure syndrome. Curr Opin Mol Ther 7:461–466

    CAS  PubMed  Google Scholar 

  • Wirth T (2011) A short perspective on gene therapy: clinical experience on gene therapy of gliomablastoma multiforme. World J Exp Med 1:10–16

    PubMed  PubMed Central  Google Scholar 

  • Witt R, MacKenzie TC, Peranteau WH (2017) Fetal stem cell and gene therapy. Semin Fetal Neonatal Med 22(6):410–414

    PubMed  Google Scholar 

  • Wu Y, Zhou H, Fan X, Zhang Y, Zhang M et al (2015) Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells. Cell Res 25:67–79

    CAS  PubMed  Google Scholar 

  • Xin H, Kanehira M, Mizuguchi H, Hayakawa T, Kikuchi T et al (2007) Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells. Stem Cells 25:1618–1626

    CAS  PubMed  Google Scholar 

  • Xu G, Guo Y, Seng Z, Cui G, Qu J (2015) Bone marrow-derived mesenchymal stem cells co-expressing interleukin-18 and interferon-beta exhibit potent antitumor effect against intracranial glioma in rats. Oncol Rep 34:1915–1922

    CAS  PubMed  Google Scholar 

  • Yan C, Li S, Li Z, Peng H, Yuan X et al (2013) Human umbilical cord mesenchymal stem cells as vehicles of CD20-specific TRAIL fusion protein delivery: a double-target therapy against non-Hodgkin’s lymphoma. Mol Pharm 10:142–151

    CAS  PubMed  Google Scholar 

  • Yang B, Qiu Y, Zhou N, Ouyang H, Ding J et al (2017) Application of stem cells in oral disease therapy: progresses and perspectives. Front Physiol 8:197

    PubMed  PubMed Central  Google Scholar 

  • Yap NY, Rajandram R, Ng KL, Pailoor J, Fadzli A, Gobe GC (2015) Genetic and chromosomal aberrations and their clinical significance in renal neoplasms. Biomed Res Int 2015:476508

    PubMed  PubMed Central  Google Scholar 

  • Yi BR, O SN, Kang NH, Hwang KA, Kim SU et al (2011) Genetically engineered stem cells expressing cytosine deaminase and interferon-beta migrate to human lung cancer cells and have potentially therapeutic anti-tumor effects. Int J Oncol 39:833–839

    CAS  PubMed  Google Scholar 

  • Yi BR, Park MA, Lee HR, Kang NH, Choi KJ et al (2013) Suppression of the growth of human colorectal cancer cells by therapeutic stem cells expressing cytosine deaminase and interferon-beta via their tumor-tropic effect in cellular and xenograft mouse models. Mol Oncol 7:543–554

    CAS  PubMed  PubMed Central  Google Scholar 

  • Yi BR, Kim SU, Choi KC (2015) Additional effects of engineered stem cells expressing a therapeutic gene and interferon-beta in a xenograft mouse model of endometrial cancer. Int J Oncol 47:171–178

    CAS  PubMed  Google Scholar 

  • Yin PT, Shah S, Pasquale NJ, Garbuzenko OB, Minko T, Lee KB (2016) Stem cell-based gene therapy activated using magnetic hyperthermia to enhance the treatment of cancer. Biomaterials 81:46–57

    CAS  PubMed  Google Scholar 

  • Yoshida T, Ohnami S, Aoki K (2004) Development of gene therapy to target pancreatic cancer. Cancer Sci 95:283–289

    CAS  PubMed  Google Scholar 

  • Yoshimura N, Kato R, Chancellor MB, Nelson JB, Glorioso JC (2010) Gene therapy as future treatment of erectile dysfunction. Expert Opin Biol Ther 10:1305–1314

    CAS  PubMed  PubMed Central  Google Scholar 

  • You Q, Yao Y, Zhang Y, Fu S, Du M, Zhang G (2015) Effect of targeted ovarian cancer therapy using amniotic fluid mesenchymal stem cells transfected with enhanced green fluorescent protein-human interleukin-2 in vivo. Mol Med Rep 12:4859–4866

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang QS (2017) Stem cell therapy for Fanconi anemia. Adv Exp Med Biol 1–10

    Google Scholar 

  • Zhang S, Chen S, Li W, Guo X, Zhao P et al (2011) Rescue of ATP7B function in hepatocyte-like cells from Wilson’s disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. Hum Mol Genet 20:3176–3187

    CAS  PubMed  Google Scholar 

  • Zhang B, Shan H, Li D, Li ZR, Zhu KS, Jiang ZB (2012) The inhibitory effect of MSCs expressing TRAIL as a cellular delivery vehicle in combination with cisplatin on hepatocellular carcinoma. Cancer Biol Ther 13:1175–1184

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang D, Zheng L, Shi H, Chen X, Wan Y et al (2014a) Suppression of peritoneal tumorigenesis by placenta-derived mesenchymal stem cells expressing endostatin on colorectal cancer. Int J Med Sci 11:870–879

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zhang TY, Huang B, Yuan ZY, Hu YL, Tabata Y, Gao JQ (2014b) Gene recombinant bone marrow mesenchymal stem cells as a tumor-targeted suicide gene delivery vehicle in pulmonary metastasis therapy using non-viral transfection. Nanomedicine 10:257–267

    CAS  PubMed  Google Scholar 

  • Zhang Y, Wang J, Ren M, Li M, Chen D et al (2014c) Gene therapy of ovarian cancer using IL-21-secreting human umbilical cord mesenchymal stem cells in nude mice. J Ovarian Res 7:8

    PubMed  PubMed Central  Google Scholar 

  • Zhang J, Hou L, Wu X, Zhao D, Wang Z et al (2016) Inhibitory effect of genetically engineered mesenchymal stem cells with Apoptin on hepatoma cells in vitro and in vivo. Mol Cell Biochem 416:193–203

    CAS  PubMed  Google Scholar 

  • Zhao WH, Cheng JX, Shi PF, Huang JY (2011) [Human umbilical cord mesenchymal stem cells with adenovirus-mediated interleukin 12 gene transduction inhibits the growth of ovarian carcinoma cells both in vitro and in vivo]. Nan fang yi ke da xue xue bao 31:903–907

    Google Scholar 

  • Zhao Y, Lam DH, Yang J, Lin J, Tham CK et al (2012) Targeted suicide gene therapy for glioma using human embryonic stem cell-derived neural stem cells genetically modified by baculoviral vectors. Gene Ther 19:189–200

    CAS  PubMed  Google Scholar 

  • Zhong XG, He S, Yin W, Deng JY, Chen B (2005) [Tropism of adult liver stem cells toward hepatocellular carcinoma cells in vitro]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi 13:644–647

    Google Scholar 

  • Zhong XG, He S, Yin W, Deng JY, Cheng B (2007) Selective tropism of liver stem cells to hepatocellular carcinoma in vivo. World J Gastroenterol 13:3886–3891

    PubMed  PubMed Central  Google Scholar 

  • Zhou Y, Abel GA, Hamilton W, Pritchard-Jones K, Gross CP et al (2017) Diagnosis of cancer as an emergency: a critical review of current evidence. Nat Rev Clin Oncol 14:45–56

    PubMed  Google Scholar 

  • Zhu X, Su D, Xuan S, Ma G, Dai Z et al (2013) Gene therapy of gastric cancer using LIGHT-secreting human umbilical cord blood-derived mesenchymal stem cells. Gastric Cancer 16:155–166

    CAS  PubMed  Google Scholar 

  • Zhu D, Chen C, Purwanti YI, Du S, Lam DH et al (2014a) Induced pluripotent stem cell-derived neural stem cells transduced with baculovirus encoding CD40 ligand for immunogene therapy in mouse models of breast cancer. Hum Gene Ther 25:747–758

    CAS  PubMed  Google Scholar 

  • Zhu Y, Cheng M, Yang Z, Zeng CY, Chen J et al (2014b) Mesenchymal stem cell-based NK4 gene therapy in nude mice bearing gastric cancer xenografts. Drug Des Devel Ther 8:2449–2462

    CAS  PubMed  PubMed Central  Google Scholar 

  • Zischek C, Niess H, Ischenko I, Conrad C, Huss R et al (2009) Targeting tumor stroma using engineered mesenchymal stem cells reduces the growth of pancreatic carcinoma. Ann Surg 250:747–753

    PubMed  Google Scholar 

  • Zolochevska O, Yu G, Gimble JM, Figueiredo ML (2012) Pigment epithelial-derived factor and melanoma differentiation associated gene-7 cytokine gene therapies delivered by adipose-derived stromal/mesenchymal stem cells are effective in reducing prostate cancer cell growth. Stem Cells Dev 21:1112–1123

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Health Research Institute, Thalassemia and Hemoglobinopathies Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran

    Fakher Rahim

  2. Cell Therapy and Regenerative Medicine Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Babak Arjmand

  3. Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Babak Arjmand

  4. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Bagher Larijani

  5. Brain and Spinal Cord Injury Research Center, Tehran University of Medical Sciences, Tehran, Iran

    Parisa Goodarzi

Authors
  1. Fakher Rahim
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Babak Arjmand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bagher Larijani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Parisa Goodarzi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Laboratory of Stem Cell Research and Application & Stem Cell Institute & Cancer Research Laboratory, VNUHCM University of Science, Ho Chi Minh City, Vietnam

    Phuc Van Pham

  2. University of Edinburgh - Zhejiang, International Campus (UoE-ZJU), Haining, Zhejiang, China

    Ahmed El-Hashash

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rahim, F., Arjmand, B., Larijani, B., Goodarzi, P. (2018). Stem Cells Treatment to Combat Cancer and Genetic Disease: From Stem Cell Therapy to Gene-Editing Correction. In: Pham, P., El-Hashash, A. (eds) Stem Cells for Cancer and Genetic Disease Treatment. Stem Cells in Clinical Applications. Springer, Cham. https://doi.org/10.1007/978-3-319-98065-2_3

Download citation

Publish with us

Policies and ethics

Search

Navigation